E. coli antibodies in schizophrenia

Psychological Medicine

Volumn 16, Issue 1, 1986, Pages 209-211

  Kroll J ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; ESCHERICHIA COLI; HUMAN; LARGE INTESTINE; SCHIZOPHRENIA;

ADULT; AGED; ANTIBODIES, BACTERIAL; ESCHERICHIA COLI; HUMAN; IMMUNOGLOBULINS; MALE; MIDDLE AGE; NEUROTIC DISORDERS; PORTAL VEIN; SCHIZOPHRENIA;

EID: 0022572082     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700002646     Document Type: Article

References (16)

1. Alvarez, R. G. & Kazimierczak, W. (1981). New light on the mechanism of action of disodium cromoglycate. Agents and Actions 11, 94–96.
2. Buscaino, G. A. (1978). The amino-hepato-entero-toxic theory of schizophrenia: an historical evaluation. In The Biological Basis of Schizophrenia (ed. G. Hemmings and W. A. Hemmings), pp. 45–54. MTP Press: Lancaster.
3. Dohan, F. C. & Grasberger, J. C. (1973). Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry 130, 685–688.
4. Galbraith, R. M., Williams, R., Pattison, J., Kennedy, L. A., Eddleston, A. L. W. F., Webster, A. O. B., Doniac, D. & Batchelor, J. T. (1976). Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet 1, 930–934.
5. Hekkens, J. M. (1978). Antibodies to gliadin in serum of normals, coeliac patients and schizophrenics. In The Biological Basis of Schizophrenia (ed. G. Hemmings and W. A. Hemmings), pp. 259–261. MTP Press: Lancaster.
6. Kashyap, N., Sharma, D. P., Mukhopadhyay, S., Nundy, S. & Bhargava, S. (1983). Evaluation of techniques for assessment of portasystemic shunt patency. Indian Journal of Medical Research 78, 841–846.
7. Kinnell, H. G., Kirkwood, E. & Lewis, C. (1982). Food antibodies in schizophrenia. Psychological Medicine 12, 85–89.
8. Kroll, J. (1965). Liver dysfunction and schizophrenia. Lancet 1, 763–764.
9. Kroll, J. (1983). Line immunoelectrophoresis. Scandinavian Journal of Immunology 17, Supplement 10, 151–163.
10. Kroll, J. & Fog, R. (1968). Portal-systemic shunts and mental disorders. Acta Psychiatrica Scandinavica 44, 255–260
11. Kroll, J., Jensen, K. A. & Lyngbye, J. (1969). Quantitative immunoelectrophoresis as routine analysis. In Methods in Clinical Chemistry, Vol. 1 (ed. M. Roth), pp. 131–139. S. Karger: Basle.
12. Martin, L. W. & Bryant, L. R. (1962). The use of fructose to determine the patency of portal-systemic shunts. Archives of Surgery 85, 783–791.
13. Mascord, I., Freed, D. & Durrant, B. (1978). Antibodies to foodstuffs in schizophrenia. British Medical Journal 2, 1351.
14. Prytz, H., Bjϕmeboe, M., Staehr Johansen, T. & ϕrskov, F. (1974). The influence of portasystemic shunt operation on immunoglobulins and Escheria coli antibodies in patients with cirrhosis of liver. Acta Medica Scandinavica 196, 109–112.
15. Triger, D. R., Boyer, T. D., Redeker, A. G., Reynolds, T. B. & Waxman, A. D. (1979). Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure and E. coli antibodies. Digestive Diseases and Sciences 24 (7), 509–513.
16. Voorhees, A. B., Chaitman, E., Schneider, S., Nicholson, J. F., Kornfeld, D. S. & Price, J. (1973). Portal-systemic encephalopathy in the non-cirrhotic patient. Effect of portal-systemic shunting. Archives of Surgery 107, 659–663.